PMID- 36714104 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230202 IS - 2296-858X (Print) IS - 2296-858X (Electronic) IS - 2296-858X (Linking) VI - 9 DP - 2022 TI - Vietnam Association of Gastroenterology (VNAGE) consensus on the management of Helicobacter pylori infection. PG - 1065045 LID - 10.3389/fmed.2022.1065045 [doi] LID - 1065045 AB - Helicobacter pylori (H. pylori) infection is prevalent and has a rapidly increasing antibiotic resistance rate in Vietnam. Reinfection is quite common, and gastric carcinoma remains one of the most common malignancies, which is not uncommon to develop after successful eradication. The purpose of this consensus is to provide updated recommendations on the management of H. pylori infection in the country. The consensus panel consisted of 32 experts from 14 major universities and institutions in Vietnam who were invited to review the evidence and develop the statements using the Delphi method. The process followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The consensus level was defined as >/=80% for agreement on the proposed statements. Due to the limited availability of high-quality local evidence, this consensus was also based on high-quality evidence from international studies, especially those conducted in other populations in the Asia-Pacific region. The panel finally reached a consensus on 27 statements after two voting rounds, which consisted of four sections (1) indications for testing and selection of diagnostic tests (2), treatment regimens, (3) post-treatment confirmation of H. pylori status, and (4) reinfection prevention methods and follow-up after eradication. Important issues that require further evidence include studies on third-line regimens, strategies to prevent H. pylori reinfection, and post-eradication follow-up for precancerous gastric lesions. We hope this consensus will help guide the current clinical practice in Vietnam and promote multicenter studies in the country and international collaborations. CI - Copyright (c) 2023 Quach, Mai, Tran, Dao, Tran, Vu, Vu, Pham, Bui, Ho, Trinh, Nguyen, Duong, Tran, Nguyen, Nguyen, Nguyen, Nguyen, Dao, Thai, Phan, Le, Vo, Ho, Nguyen, Le, Le, Phan, Nguyen, Tran, Tran and Ta. FAU - Quach, Duc Trong AU - Quach DT AD - Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. AD - Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, Vietnam. FAU - Mai, Bang Hong AU - Mai BH AD - 108 Military Central Hospital, Hanoi, Vietnam. FAU - Tran, Mien Kieu AU - Tran MK AD - Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. FAU - Dao, Long Van AU - Dao LV AD - Internal Medicine Faculty, Hanoi Medical University, Hanoi, Vietnam. FAU - Tran, Huy Van AU - Tran HV AD - Hue University of Medicine and Pharmacy, Hue, Vietnam. FAU - Vu, Khanh Truong AU - Vu KT AD - Tam Anh Hospital, Hanoi, Vietnam. FAU - Vu, Khien Van AU - Vu KV AD - 108 Military Central Hospital, Hanoi, Vietnam. FAU - Pham, Ho Thi-Thu AU - Pham HT AD - Internal Medicine Faculty, Hanoi Medical University, Hanoi, Vietnam. FAU - Bui, Hoang Huu AU - Bui HH AD - Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. FAU - Ho, Dung Dang-Quy AU - Ho DD AD - Cho Ray Hospital, Ho Chi Minh City, Vietnam. FAU - Trinh, Dung Tuan AU - Trinh DT AD - Tam Anh Hospital, Hanoi, Vietnam. FAU - Nguyen, Vinh Thuy AU - Nguyen VT AD - Department of Internal Medicine, Hanoi National University, Hanoi, Vietnam. FAU - Duong, Thai Hong AU - Duong TH AD - Department of Internal Medicine, Thai Nguyen University of Medicine and Pharmacy, Thai Nguyen, Vietnam. FAU - Tran, Tuong Thi-Khanh AU - Tran TT AD - Department of Internal Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam. FAU - Nguyen, Ha Thi-Viet AU - Nguyen HT AD - Internal Medicine Faculty, Hanoi Medical University, Hanoi, Vietnam. FAU - Nguyen, Thinh Tien AU - Nguyen TT AD - 108 Military Central Hospital, Hanoi, Vietnam. FAU - Nguyen, Thang Duy AU - Nguyen TD AD - Institute of Gastroenterology and Hepatology, Hanoi, Vietnam. FAU - Nguyen, Long Cong AU - Nguyen LC AD - Bach Mai Hospital, Hanoi, Vietnam. FAU - Dao, Hang Viet AU - Dao HV AD - Internal Medicine Faculty, Hanoi Medical University, Hanoi, Vietnam. FAU - Thai, Ky Doan AU - Thai KD AD - 108 Military Central Hospital, Hanoi, Vietnam. FAU - Phan, Nam Trung AU - Phan NT AD - Hue University of Medicine and Pharmacy, Hue, Vietnam. FAU - Le, Ly Thanh AU - Le LT AD - Cho Ray Hospital, Ho Chi Minh City, Vietnam. FAU - Vo, Cong Hong-Minh AU - Vo CH AD - Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, Vietnam. FAU - Ho, Phat Tan AU - Ho PT AD - Cho Ray Hospital, Ho Chi Minh City, Vietnam. FAU - Nguyen, Tung Lam AU - Nguyen TL AD - 108 Military Central Hospital, Hanoi, Vietnam. FAU - Le, Quang Dinh AU - Le QD AD - Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. FAU - Le, Nho Viet AU - Le NV AD - Department of Internal Medicine, Da Nang University of Medical Technology and Pharmacy, Da Nang, Vietnam. FAU - Phan, Hoan Quoc AU - Phan HQ AD - 108 Military Central Hospital, Hanoi, Vietnam. FAU - Nguyen, Binh Canh AU - Nguyen BC AD - 108 Military Central Hospital, Hanoi, Vietnam. FAU - Tran, Trung Thien AU - Tran TT AD - Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. FAU - Tran, Tu Viet AU - Tran TV AD - 103 Military Hospital, Hanoi, Vietnam. FAU - Ta, Long AU - Ta L AD - 108 Military Central Hospital, Hanoi, Vietnam. LA - eng PT - Journal Article PT - Review DEP - 20230112 PL - Switzerland TA - Front Med (Lausanne) JT - Frontiers in medicine JID - 101648047 PMC - PMC9878302 OTO - NOTNLM OT - Helicobacter pylori OT - Vietnam OT - consensus OT - diagnosis OT - eradication OT - guidelines OT - management COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/01/31 06:00 MHDA- 2023/01/31 06:01 PMCR- 2023/01/12 CRDT- 2023/01/30 04:24 PHST- 2022/10/09 00:00 [received] PHST- 2022/12/21 00:00 [accepted] PHST- 2023/01/30 04:24 [entrez] PHST- 2023/01/31 06:00 [pubmed] PHST- 2023/01/31 06:01 [medline] PHST- 2023/01/12 00:00 [pmc-release] AID - 10.3389/fmed.2022.1065045 [doi] PST - epublish SO - Front Med (Lausanne). 2023 Jan 12;9:1065045. doi: 10.3389/fmed.2022.1065045. eCollection 2022.